Marker Therapeutics (MRKR) Stock Chart & Stock Price History $1.29 +0.08 (+6.61%) As of 03:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Marker Therapeutics Stock Price Performance The Marker Therapeutics (MRKR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 64.66%, with a year-to-date return of -58.52%. In the past month, the stock has decreased 18.35%, reflecting recent market activity. As of the latest close, Marker Therapeutics traded at $1.21 with a market cap of $15.66 million and volume of 58,468 shares. Five years ago, the stock traded at $1.82, representing a 29.12% decrease over that period. At the time, it had a market cap of $88.57 million and a volume of 133,600 shares. Receive MRKR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.38%1 Month Performance-18.35%3 Month Performance+14.16%Year-To-Date Performance-58.52%1 Year Performance-64.66%5 Year Performance-29.12% MRKR Stock Chart for Friday, August, 22, 2025 MRKR Chart by TradingView Marker Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$1.16$1.21+4.31%$1.23$1.1458,468 shs$15.66 million08/20/2025$1.13$1.16+2.65%$1.19$1.11162,355 shs$15.01 million08/19/2025$1.21$1.13-6.61%$1.21$1.13152,068 shs$12.79 million08/18/2025$1.26$1.21-3.97%$1.28$1.20129,526 shs$13.69 million08/15/2025$1.25$1.26+0.80%$1.32$1.23101,950 shs$14.25 million08/14/2025$1.29$1.25-3.10%$1.29$1.23139,542 shs$14.14 million08/13/2025$1.28$1.29+0.78%$1.32$1.25121,700 shs$14.60 million08/12/2025$1.19$1.28+7.56%$1.29$1.18209,719 shs$14.48 million08/11/2025$1.19$1.19$1.20$1.10125,046 shs$13.46 million08/08/2025$1.23$1.19-3.25%$1.24$1.1782,321 shs$13.46 million Get the Latest News and Ratings for MRKR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$1.21$1.23+1.65%$1.25$1.15174,946 shs$13.92 million08/06/2025$1.25$1.21-3.20%$1.27$1.18171,903 shs$13.69 million08/05/2025$1.24$1.25+0.81%$1.33$1.23108,208 shs$14.14 million08/04/2025$1.35$1.24-8.15%$1.35$1.22259,400 shs$14.03 million08/01/2025$1.40$1.35-3.57%$1.40$1.29176,676 shs$15.27 million07/31/2025$1.38$1.40+1.45%$1.44$1.37157,099 shs$15.84 million07/30/2025$1.41$1.38-2.13%$1.50$1.37240,862 shs$15.61 million07/29/2025$1.55$1.41-9.03%$1.61$1.41287,774 shs$15.95 million07/28/2025$1.56$1.55-0.64%$1.58$1.51163,855 shs$17.54 million07/25/2025$1.50$1.56+4.00%$1.56$1.47202,281 shs$17.65 million07/24/2025$1.60$1.50-6.25%$1.62$1.41265,133 shs$16.97 million07/23/2025$1.58$1.60+1.27%$1.65$1.51270,841 shs$18.10 million07/22/2025$1.53$1.58+3.27%$1.62$1.43653,581 shs$17.88 million07/21/2025$1.70$1.53-10.00%$1.75$1.411.07 million shs$17.30 million Related Companies Eliem Therapeutics Stock Price Chart Verrica Pharmaceuticals Stock Price Chart ABVC BioPharma Stock Price Chart Precision BioSciences Stock Price Chart PDS Biotechnology Stock Price Chart ImmuCell Stock Price Chart Annovis Bio Stock Price Chart Actinium Pharmaceuticals Stock Price Chart Karyopharm Therapeutics Stock Price Chart Barinthus Biotherapeutics Stock Price Chart Receive MRKR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MRKR) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marker Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marker Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access